Nexgon Pharma

Nexgen Pharma was a U.S. pharmaceutical development and manufacturing company focused on Rx and OTC drugs, dietary supplements, and medical foods. The company provided formulation development, ANDA-related support, and commercial manufacturing across solid dose, powder, semi-solid, and liquid products. Publicly available records indicate it manufactured products for partners including marketed small-molecule products such as Chenodal and supported collaborative development in cough-and-cold products. Its formulation development and drug product contract manufacturing business was acquired by LGM Pharma in July 2020. The company appears to have ceased operating independently after that transaction, with historical operations centered in Irvine, California and additional U.S. manufacturing sites.